Antares Pharma, Inc. EBITDA Margin 2010-2022 | ATRS
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Antares Pharma, Inc. (ATRS) over the last 10 years. The current EBITDA margin for Antares Pharma, Inc. as of March 31, 2022 is .
EBITDA Margin Historical Data |
Date |
TTM Revenue |
TTM EBITDA |
EBITDA Margin |
2022-03-31 |
$0.18B |
$0.06B |
33.70% |
2021-12-31 |
$0.18B |
$0.07B |
38.04% |
2021-09-30 |
$0.18B |
$0.03B |
16.76% |
2021-06-30 |
$0.17B |
$0.03B |
15.79% |
2021-03-31 |
$0.16B |
$0.02B |
14.56% |
2020-12-31 |
$0.15B |
$0.02B |
10.74% |
2020-09-30 |
$0.14B |
$0.02B |
10.49% |
2020-06-30 |
$0.14B |
$0.01B |
8.76% |
2020-03-31 |
$0.13B |
$0.01B |
5.26% |
2019-12-31 |
$0.12B |
$0.00B |
3.25% |
2019-09-30 |
$0.10B |
$0.01B |
5.77% |
2019-06-30 |
$0.09B |
$0.00B |
2.27% |
2019-03-31 |
$0.07B |
0 |
0.00% |
2018-12-31 |
$0.06B |
$-0.00B |
-1.56% |
2018-09-30 |
$0.06B |
$-0.01B |
-20.34% |
2018-06-30 |
$0.06B |
$-0.02B |
-26.79% |
2018-03-31 |
$0.06B |
$-0.01B |
-25.45% |
2017-12-31 |
$0.05B |
$-0.01B |
-24.07% |
2017-09-30 |
$0.05B |
$-0.01B |
-25.93% |
2017-06-30 |
$0.05B |
$-0.02B |
-30.77% |
2017-03-31 |
$0.05B |
$-0.02B |
-39.22% |
2016-12-31 |
$0.05B |
$-0.02B |
-45.10% |
2016-09-30 |
$0.05B |
$-0.03B |
-51.02% |
2016-06-30 |
$0.05B |
$-0.02B |
-51.06% |
2016-03-31 |
$0.05B |
$-0.02B |
-38.78% |
2015-12-31 |
$0.05B |
$-0.02B |
-40.00% |
2015-09-30 |
$0.04B |
$-0.02B |
-53.66% |
2015-06-30 |
$0.04B |
$-0.02B |
-64.86% |
2015-03-31 |
$0.03B |
$-0.03B |
-110.34% |
2014-12-31 |
$0.03B |
$-0.04B |
-134.62% |
2014-09-30 |
$0.02B |
$-0.03B |
-134.78% |
2014-06-30 |
$0.02B |
$-0.03B |
-136.36% |
2014-03-31 |
$0.02B |
$-0.03B |
-118.18% |
2013-12-31 |
$0.02B |
$-0.02B |
-90.91% |
2013-09-30 |
$0.02B |
$-0.02B |
-82.61% |
2013-06-30 |
$0.02B |
$-0.02B |
-69.57% |
2013-03-31 |
$0.02B |
$-0.01B |
-63.64% |
2012-12-31 |
$0.02B |
$-0.01B |
-45.83% |
2012-09-30 |
$0.02B |
$-0.01B |
-26.09% |
2012-06-30 |
$0.02B |
$-0.00B |
-19.05% |
2012-03-31 |
$0.02B |
$-0.00B |
-15.00% |
2011-12-31 |
$0.02B |
$-0.00B |
-23.53% |
2011-09-30 |
$0.02B |
$-0.01B |
-33.33% |
2011-06-30 |
$0.01B |
$-0.01B |
-42.86% |
2011-03-31 |
$0.01B |
$-0.01B |
-46.15% |
2010-12-31 |
$0.01B |
$-0.01B |
-58.33% |
2010-09-30 |
$0.01B |
$-0.01B |
-66.67% |
2010-06-30 |
$0.01B |
$-0.01B |
-72.73% |
2010-03-31 |
$0.01B |
$-0.01B |
-80.00% |
2009-12-31 |
$0.01B |
$-0.01B |
-88.89% |